Expression of β-Catenin in Prostatic Adenocarcinomas

A Comparison with Colorectal Adenocarcinomas

Tarek A. Bismar, Peter A. Humphrey, David Grignon, Hanlin L. Wang

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

We studied 101 prostatic adenocarcinomas (72 acinar, 29 ductal) and 16 cases with high-grade prostatic intraepithelial neoplasia (HPIN) immunohistochemically for the expression of β-catenin and compared the staining patterns with those of nonneoplastic prostatic epithelium and 24 colorectal adenocarcinomas. While nuclear staining for β-catenin was evident in 20 (83%) colorectal adenocarcinomas, predominantly membranous staining was observed in 89 prostatic adenocarcinomas (88%); the remaining 12 cases showed no immunoreactivity. In prostatic tumors expressing β-catenin, staining intensity was comparable, increased, and decreased in 81, 4, and 4 cases, respectively, compared with adjacent nonneoplastic prostatic epithelium. No prostatic adenocarcinomas demonstrated nuclear staining. The β-catenin staining characteristics in HPIN were comparable to those in nonneoplastic prostatic epithelium. Negative staining for cytokeratins (CKs) 7 and 20, high-molecular-weight (HMW) CK, and villin and positive staining for prostate-specific antigen (PSA) were seen in 22 prostatic adenocarcinomas examined, in contrast with colorectal adenocarcinomas, which stained positively for CK20 and villin and negatively for CK7, HMWCK, and PSA. These data suggest that the β-catenin signaling pathway acts differently in prostatic than in colorectal tumorigenesis. The immunophenotypes documented herein also might aid in the distinction between prostatic and colorectal origins when metastasis is encountered.

Original languageEnglish (US)
Pages (from-to)557-563
Number of pages7
JournalAmerican Journal of Clinical Pathology
Volume121
Issue number4
DOIs
StatePublished - Apr 2004
Externally publishedYes

Fingerprint

Catenins
Adenocarcinoma
Staining and Labeling
Prostatic Intraepithelial Neoplasia
Epithelium
Prostate-Specific Antigen
Keratin-20
Keratin-7
Negative Staining
Keratins
Carcinogenesis
Molecular Weight
Neoplasm Metastasis

Keywords

  • β-Catenin
  • Adenocarcinoma
  • Colorectal
  • Immunohistochemistry
  • Prostate

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Expression of β-Catenin in Prostatic Adenocarcinomas : A Comparison with Colorectal Adenocarcinomas. / Bismar, Tarek A.; Humphrey, Peter A.; Grignon, David; Wang, Hanlin L.

In: American Journal of Clinical Pathology, Vol. 121, No. 4, 04.2004, p. 557-563.

Research output: Contribution to journalArticle

@article{be52c5b40e6e45768af9f6c7149625ef,
title = "Expression of β-Catenin in Prostatic Adenocarcinomas: A Comparison with Colorectal Adenocarcinomas",
abstract = "We studied 101 prostatic adenocarcinomas (72 acinar, 29 ductal) and 16 cases with high-grade prostatic intraepithelial neoplasia (HPIN) immunohistochemically for the expression of β-catenin and compared the staining patterns with those of nonneoplastic prostatic epithelium and 24 colorectal adenocarcinomas. While nuclear staining for β-catenin was evident in 20 (83{\%}) colorectal adenocarcinomas, predominantly membranous staining was observed in 89 prostatic adenocarcinomas (88{\%}); the remaining 12 cases showed no immunoreactivity. In prostatic tumors expressing β-catenin, staining intensity was comparable, increased, and decreased in 81, 4, and 4 cases, respectively, compared with adjacent nonneoplastic prostatic epithelium. No prostatic adenocarcinomas demonstrated nuclear staining. The β-catenin staining characteristics in HPIN were comparable to those in nonneoplastic prostatic epithelium. Negative staining for cytokeratins (CKs) 7 and 20, high-molecular-weight (HMW) CK, and villin and positive staining for prostate-specific antigen (PSA) were seen in 22 prostatic adenocarcinomas examined, in contrast with colorectal adenocarcinomas, which stained positively for CK20 and villin and negatively for CK7, HMWCK, and PSA. These data suggest that the β-catenin signaling pathway acts differently in prostatic than in colorectal tumorigenesis. The immunophenotypes documented herein also might aid in the distinction between prostatic and colorectal origins when metastasis is encountered.",
keywords = "β-Catenin, Adenocarcinoma, Colorectal, Immunohistochemistry, Prostate",
author = "Bismar, {Tarek A.} and Humphrey, {Peter A.} and David Grignon and Wang, {Hanlin L.}",
year = "2004",
month = "4",
doi = "10.1309/4470-49GV-52H7-D258",
language = "English (US)",
volume = "121",
pages = "557--563",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - Expression of β-Catenin in Prostatic Adenocarcinomas

T2 - A Comparison with Colorectal Adenocarcinomas

AU - Bismar, Tarek A.

AU - Humphrey, Peter A.

AU - Grignon, David

AU - Wang, Hanlin L.

PY - 2004/4

Y1 - 2004/4

N2 - We studied 101 prostatic adenocarcinomas (72 acinar, 29 ductal) and 16 cases with high-grade prostatic intraepithelial neoplasia (HPIN) immunohistochemically for the expression of β-catenin and compared the staining patterns with those of nonneoplastic prostatic epithelium and 24 colorectal adenocarcinomas. While nuclear staining for β-catenin was evident in 20 (83%) colorectal adenocarcinomas, predominantly membranous staining was observed in 89 prostatic adenocarcinomas (88%); the remaining 12 cases showed no immunoreactivity. In prostatic tumors expressing β-catenin, staining intensity was comparable, increased, and decreased in 81, 4, and 4 cases, respectively, compared with adjacent nonneoplastic prostatic epithelium. No prostatic adenocarcinomas demonstrated nuclear staining. The β-catenin staining characteristics in HPIN were comparable to those in nonneoplastic prostatic epithelium. Negative staining for cytokeratins (CKs) 7 and 20, high-molecular-weight (HMW) CK, and villin and positive staining for prostate-specific antigen (PSA) were seen in 22 prostatic adenocarcinomas examined, in contrast with colorectal adenocarcinomas, which stained positively for CK20 and villin and negatively for CK7, HMWCK, and PSA. These data suggest that the β-catenin signaling pathway acts differently in prostatic than in colorectal tumorigenesis. The immunophenotypes documented herein also might aid in the distinction between prostatic and colorectal origins when metastasis is encountered.

AB - We studied 101 prostatic adenocarcinomas (72 acinar, 29 ductal) and 16 cases with high-grade prostatic intraepithelial neoplasia (HPIN) immunohistochemically for the expression of β-catenin and compared the staining patterns with those of nonneoplastic prostatic epithelium and 24 colorectal adenocarcinomas. While nuclear staining for β-catenin was evident in 20 (83%) colorectal adenocarcinomas, predominantly membranous staining was observed in 89 prostatic adenocarcinomas (88%); the remaining 12 cases showed no immunoreactivity. In prostatic tumors expressing β-catenin, staining intensity was comparable, increased, and decreased in 81, 4, and 4 cases, respectively, compared with adjacent nonneoplastic prostatic epithelium. No prostatic adenocarcinomas demonstrated nuclear staining. The β-catenin staining characteristics in HPIN were comparable to those in nonneoplastic prostatic epithelium. Negative staining for cytokeratins (CKs) 7 and 20, high-molecular-weight (HMW) CK, and villin and positive staining for prostate-specific antigen (PSA) were seen in 22 prostatic adenocarcinomas examined, in contrast with colorectal adenocarcinomas, which stained positively for CK20 and villin and negatively for CK7, HMWCK, and PSA. These data suggest that the β-catenin signaling pathway acts differently in prostatic than in colorectal tumorigenesis. The immunophenotypes documented herein also might aid in the distinction between prostatic and colorectal origins when metastasis is encountered.

KW - β-Catenin

KW - Adenocarcinoma

KW - Colorectal

KW - Immunohistochemistry

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=1642270365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642270365&partnerID=8YFLogxK

U2 - 10.1309/4470-49GV-52H7-D258

DO - 10.1309/4470-49GV-52H7-D258

M3 - Article

VL - 121

SP - 557

EP - 563

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -